370 related articles for article (PubMed ID: 24350582)
1. Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.
Ralph AP; Fittock M; Schultz R; Thompson D; Dowden M; Clemens T; Parnaby MG; Clark M; McDonald MI; Edwards KN; Carapetis JR; Bailie RS
BMC Health Serv Res; 2013 Dec; 13():525. PubMed ID: 24350582
[TBL] [Abstract][Full Text] [Related]
2. Priorities for improved management of acute rheumatic fever and rheumatic heart disease: analysis of cross-sectional continuous quality improvement data in Aboriginal primary healthcare centres in Australia.
Katzenellenbogen JM; Bond-Smith D; Ralph AP; Wilmot M; Marsh J; Bailie R; Matthews V
Aust Health Rev; 2020 Apr; 44(2):212-221. PubMed ID: 32241338
[TBL] [Abstract][Full Text] [Related]
3. Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community.
Eissa S; Lee R; Binns P; Garstone G; McDonald M
Aust N Z J Public Health; 2005 Dec; 29(6):521-5. PubMed ID: 16366062
[TBL] [Abstract][Full Text] [Related]
4. Adherence to secondary prevention of rheumatic fever and rheumatic heart disease in young people: an 11-year retrospective study.
Liaw J; Gorton S; Heal C; White A
Aust N Z J Public Health; 2022 Dec; 46(6):758-763. PubMed ID: 35616403
[TBL] [Abstract][Full Text] [Related]
5. Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trial.
Ralph AP; Read C; Johnston V; de Dassel JL; Bycroft K; Mitchell A; Bailie RS; Maguire GP; Edwards K; Currie BJ; Kirby A; Carapetis JR
Trials; 2016 Jan; 17():51. PubMed ID: 26818484
[TBL] [Abstract][Full Text] [Related]
6. Clinic factors associated with better delivery of secondary prophylaxis in acute rheumatic fever management.
Quinn E; Girgis S; Van Buskirk J; Matthews V; Ward JE
Aust J Gen Pract; 2019 Dec; 48(12):859-865. PubMed ID: 31774991
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic penicillin by the full moon: a novel approach in Central Australia that may help to reduce the risk of rheumatic heart disease.
Kearns TM; Schultz R; McDonald V; Andrews RM
Rural Remote Health; 2010; 10(3):1464. PubMed ID: 20795756
[TBL] [Abstract][Full Text] [Related]
8. Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High-Burden Setting: Outcome of a Stepped-Wedge, Community, Randomized Trial.
Ralph AP; de Dassel JL; Kirby A; Read C; Mitchell AG; Maguire GP; Currie BJ; Bailie RS; Johnston V; Carapetis JR
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30018165
[TBL] [Abstract][Full Text] [Related]
9. Acute rheumatic fever: adherence to secondary prophylaxis and follow up of Indigenous patients in the Katherine region of the Northern Territory.
Stewart T; McDonald R; Currie B
Aust J Rural Health; 2007 Aug; 15(4):234-40. PubMed ID: 17617086
[TBL] [Abstract][Full Text] [Related]
10. "Hurts less, lasts longer"; a qualitative study on experiences of young people receiving high-dose subcutaneous injections of benzathine penicillin G to prevent rheumatic heart disease in New Zealand.
Cooper J; Enkel SL; Moodley D; Dobinson H; Andersen E; Kado JH; Barr RK; Salman S; Baker MG; Carapetis JR; Manning L; Anderson A; Bennett J
PLoS One; 2024; 19(5):e0302493. PubMed ID: 38743745
[TBL] [Abstract][Full Text] [Related]
11. High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease.
Ketema EB; Gishen NZ; Hailu A; Leul A; Hadgu A; Hagos K; Berhane S; Tsega T; Page-Sharp M; Davis TM; Moore B; Batty KT; Carapetis J; Salman S; Manning L
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009399. PubMed ID: 34115748
[TBL] [Abstract][Full Text] [Related]
12. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
[TBL] [Abstract][Full Text] [Related]
13. Ending rheumatic heart disease in Australia: the evidence for a new approach.
Wyber R; Noonan K; Halkon C; Enkel S; Cannon J; Haynes E; Mitchell AG; Bessarab DC; Katzenellenbogen JM; Bond-Smith D; Seth R; D'Antoine H; Ralph AP; Bowen AC; Brown A; Carapetis JR;
Med J Aust; 2020 Nov; 213 Suppl 10():S3-S31. PubMed ID: 33190287
[TBL] [Abstract][Full Text] [Related]
14. Acute rheumatic fever and rheumatic heart disease--priorities in prevention, diagnosis and management. A report of the CSANZ Indigenous Cardiovascular Health Conference, Alice Springs 2011.
Rémond MG; Wheaton GR; Walsh WF; Prior DL; Maguire GP
Heart Lung Circ; 2012 Oct; 21(10):632-8. PubMed ID: 22726405
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia.
Kado J; Salman S; Hand R; O'Brien M; Ralph A; Bowen AC; Page-Sharp M; Batty KT; Dolman V; Francis JR; Carapetis J; Manning L
J Antimicrob Chemother; 2022 Sep; 77(10):2679-2682. PubMed ID: 35822635
[TBL] [Abstract][Full Text] [Related]
16. The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease.
Ralph AP; Noonan S; Wade V; Currie BJ
Med J Aust; 2021 Mar; 214(5):220-227. PubMed ID: 33190309
[TBL] [Abstract][Full Text] [Related]
17. How accurate is the diagnosis of rheumatic fever in Egypt? Data from the national rheumatic heart disease prevention and control program (2006-2018).
Ghamrawy A; Ibrahim NN; Abd El-Wahab EW
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008558. PubMed ID: 32804953
[TBL] [Abstract][Full Text] [Related]
18. Secondary prevention of rheumatic heart disease in Ethiopia: a multicenter study.
Belay W; Dessie A; Ahmed H; Gedlu E; Mariyo A; Shehibo A; Tigabu Z; Aliyu MH; Soslow J
BMC Cardiovasc Disord; 2022 Feb; 22(1):26. PubMed ID: 35109807
[TBL] [Abstract][Full Text] [Related]
19. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
[TBL] [Abstract][Full Text] [Related]
20. Sharing success - understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease.
Chamberlain-Salaun J; Mills J; Kevat PM; Rémond MG; Maguire GP
BMC Cardiovasc Disord; 2016 Aug; 16(1):166. PubMed ID: 27581750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
